CD28 是一种细胞表面糖蛋白受体,主要在活化的 T 细胞上表达,属于 Ig 超家族,可提供关键的共刺激信号。其配体 CD80 和 CD86 通常位于抗原呈递细胞表面,可结合 CD28 或 CTLA-4。CD28 与亲和力相对较高的 CD80 二聚体相互作用,与亲和力较低的 CD86 单体相互作用,与 T 细胞受体 (TCR) 信号一起介导 T 细胞共刺激。CD28 驱动关键的细胞内生化事件,包括独特的磷酸化和转录信号传导、代谢以及关键细胞因子、趋化因子和生存信号的产生,这些对于 T 细胞的长期扩增和分化至关重要。最重要的是,用可溶性 CD28 拮抗剂治疗小鼠可诱导抗原特异性耐受性,从而防止自身免疫性疾病的进展和器官移植排斥。
CD28, a cell surface glycoprotein receptor, predominantly expressed on activated T cells, belongs to the Ig superfamily and provides a critical co-stimulatory signal. Its ligands, CD80 and CD86, are typically found on the surface of antigen-presenting cells and can either bind CD28 or CTLA-4. CD28 interacts with the CD80 dimer with relatively high affinity and the CD86 monomer with lower affinity, mediating T cell co-stimulation in conjunction with T cell receptor (TCR) signals. CD28 drives critical intracellular biochemical events including unique phosphorylation and transcriptional signaling, metabolism, and the production of key cytokines, chemokines, and survival signals that are essential for long-term expansion and differentiation of T cells. Most importantly, treatment of mice with a soluble CD28 antagonist induced antigen-specific tolerance that prevented the progression of autoimmune diseases and organ graft rejection.
Reltecimod (AB-103) TFA 是一种 T 细胞特异性表面糖蛋白 CD28 (TP44) 拮抗剂,对不同的细菌感染、细菌外毒素和内毒素以及电离辐射均有良好的抗性作用,并通过靶向和减弱关键的 CD28/B7-2 共刺激通路来调节炎症反应而不抑制它,可用于研究坏死性软组织感染 (NSTIs)。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号